Patrick Machado insider trades
Open-market stock purchases and sales by Patrick Machado, Director at Arcus Biosciences, Inc, from SEC Form 4 filings since Aug 17, 2016.
Track record: 20% of 5 scored buys are up 5% or more since purchase, averaging -49%.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Jun 11, 2026 | RCUS Arcus Biosciences, Inc | Bought (not open market) | — |
| Jun 11, 2026 | RCUS Arcus Biosciences, Inc | Bought (not open market) | — |
| Jun 3, 2026 | XENE Xenon Pharmaceuticals Inc | Bought (not open market) | — |
| Jun 3, 2026 | XENE Xenon Pharmaceuticals Inc | Bought (not open market) | — |
| Jun 1, 2026 | XENE Xenon Pharmaceuticals Inc | Bought (not open market) | — |
| Dec 9, 2025 | ADVM Adverum Biotechnologies, Inc | Sold (not open market) | $178K |
| Dec 9, 2025 | ADVM Adverum Biotechnologies, Inc | Sold (not open market) | $769K |
| Dec 9, 2025 | ADVM Adverum Biotechnologies, Inc | Sold (not open market) | $81.9K |
| Dec 9, 2025 | ADVM Adverum Biotechnologies, Inc | Sold (not open market) | $101K |
| Dec 9, 2025 | ADVM Adverum Biotechnologies, Inc | Sold (not open market) | $31.5K |
| Dec 9, 2025 | ADVM Adverum Biotechnologies, Inc | Sold (not open market) | — |
| Dec 9, 2025 | ADVM Adverum Biotechnologies, Inc | Sold (not open market) | $64K |
| Dec 9, 2025 | ADVM Adverum Biotechnologies, Inc | Sold (not open market) | $92.4K |
| Dec 9, 2025 | ADVM Adverum Biotechnologies, Inc | Sold (not open market) | $219K |
| Dec 9, 2025 | ADVM Adverum Biotechnologies, Inc | Sold (not open market) | $603K |
| Dec 9, 2025 | ADVM Adverum Biotechnologies, Inc | Sold (not open market) | $173K |
Companies traded
- RCUS Arcus Biosciences, Inc: other filings, last Jun 11, 2026
- XENE Xenon Pharmaceuticals Inc: other filings, last Jun 3, 2026
- ADVM Adverum Biotechnologies, Inc: 2 buys, last Dec 9, 2025
- ALMS Alumis Inc: other filings, last Jul 30, 2025
- SLRN ACELYRIN, Inc: other filings, last May 21, 2025
- CMRX Chimerix Inc: other filings, last Jun 9, 2023
- TPTX Turning Point Therapeutics, Inc: other filings, last Aug 17, 2022
- PRNB Principia Biopharma Inc: other filings, last Sep 28, 2020
- UROV Urovant Sciences Ltd: 27 buys, last Jun 19, 2019
- MYOV Myovant Sciences Ltd: 2 buys, last Jun 4, 2019
- AXON Axovant Sciences Ltd: 3 buys, last Mar 18, 2019
- ECYT Endocyte Inc: other filings, last Dec 21, 2018